Prudential Financial
CASI icon

Prudential Financial’s CASI Pharmaceuticals CASI Stock Holding History

Prudential Financial’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,000
Closed -$29K – 2605
2022
Q3 		$29K Buy
+11,000
New +$35.4K ﹤0.01% 2606
2021
Q3 		– Sell
-1,660
Closed -$26K – 2592
2021
Q2 		$26K Buy
+1,660
New +$27.9K ﹤0.01% 2534
2020
Q4 		– Sell
-5,434
Closed -$83K – 2449
2020
Q3 		$83K Buy
+5,434
New +$102K ﹤0.01% 2377

Other funds holding CASI

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $788M AUM 66.95% 1-Year Est. Return
WSC
Wellington Shields & Co New York $446M AUM 38.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Prudential Financial's CASI Position: Q4 2022 in Review

Prudential Financial sold out of CASI Pharmaceuticals (CASI) in Q4 2022, closing a stake of 11,000 shares — an estimated $29K sold.

Prudential Financial first reported a position in CASI in Q3 2020 and held it in 3 quarters. The position peaked at $83K in Q3 2020. 23 funds tracked by Wall St. Rank hold CASI as of Q4 2022.

  • Prudential Financial reported no remaining CASI Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Prudential Financial sold 11,000 CASI Pharmaceuticals shares in Q4 2022, an estimated $29K.
  • Prudential Financial first reported a position in CASI Pharmaceuticals in Q3 2020 and held it in 3 quarters.
  • Prudential Financial's CASI Pharmaceuticals position peaked at $83K in Q3 2020.
  • 23 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q4 2022.

Based on Prudential Financial's 13F filing for Q4 2022, filed 14 Feb 2023.